Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular Disease | Zendy

George Thanassoulis | Zendy; Ken Williams | Zendy; Kathleen K. Altobelli | Zendy; Michael Pencina | Zendy; Christopher P. Can | Zendy; Allan D. Sniderman | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular Disease

Author(s) -

George Thanassoulis,

Ken Williams,

Kathleen K. Altobelli,

Michael Pencina,

Christopher P. Can,

Allan D. Sniderman

Publication year - 2016

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.115.018383

Subject(s) - medicine , primary prevention , statin , hydroxymethylglutaryl coa reductase inhibitors , disease , atherosclerotic cardiovascular disease , secondary prevention , intensive care medicine , physical therapy

Current guidelines recommend statins in the primary prevention of cardiovascular disease on the basis of predicted cardiovascular risk without directly considering the expected benefits of statin therapy based on the available randomized, controlled trial evidence.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research